High dose of therapeutic ultrasound in the treatment of patellar tendinopathy

Not Applicable

Recruiting

• Conditions: Tendinopathy; Patellar Tendinopathy; C05.651.869; M76.5

• Registration Number: RBR-658n6w
• Lead Sponsor: niversidade Federal de São Paulo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-18
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Volunteers of both sexes; with diagnosis of unilateral or bilateral patellar tendinopathy; aged between 18 and 40 years-old; with localized pain at the inferior patellar pole/superior aspect of patellar tendon when perform single leg decline squat, jumping, landing, running, abruptly changing direction and with a score of less than 80 on the Victorian Institute of Sports Assessment - Patella (VISA-P) questionnaire.

Exclusion Criteria

Participants will be excluded if they present a history of nervous and/or musculoskeletal injuries in the low back spine and/or lower limbs in the last 6 months, signs and/or symptoms of other diseases and/or another disorders affecting the knees, including systemic and rheumatic diseases and/or pre-existing dysfunctions (clinically evaluated and detected), previous history of knee or patellar tendon surgery, use of intra-articular medications in the knee in the last 6 months, or pregnancy.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity will be measured using the Visual Analogue Scale (VAS). This outcome will be collected at baseline evaluations (T0), post-8 sessions - 4 weeks (T1) and post-16 sessions - 8 weeks (T2) and at each treatment session. Reductions of 3.0 points in the VAS, will demonstrate possible effectiveness of the program proposed in this study.<br>Functional impairment will be assessed with the VISA-P questionnaire. This outcome will be collected at baseline evaluations (T0), post-8 sessions - 4 weeks (T1) and post-16 sessions - 8 weeks (T2), post-3 months of protocol concluded (T3) and post-6 months of protocol concluded (T4). The effectiveness will be demonstrated if changes of 13 points will be detected.